Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8241
Reference
Drug alert 37/2024
Name
Drug Alert Class 4 Drug Alert 37 2024 – Class 4 medicines defect information – caution in use – Dawa Ltd – Trazodone Hydrochloride 50mg, 100mg capsules and 50mg/5ml oral solution
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Industry
Medicines Recall
Description
Dawa Limited has informed the MHRA of an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Trazodone Hydrochloride 50mg and 100mg Capsules and Trazodone Hydrochloride 50mg/5ml Oral Solution.
The PIL does not contain the latest safety information relating to serotonergic products (trazodone) and the interaction with buprenorphine.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2024-08-15 11:56:58
Click to go back to homepage